MedPath
NMPA Approval

Durvalumab Injection

国药准字SJ20190039

May 23, 2024

S20190039

Drug Information

度伐利尤单抗注射液

英飞凡

注射剂

120mg/2.4mL

生物制品

May 23, 2024

May 22, 2029

Company Information

Applicant Company

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA

Manufacturing Company

1300 South Patterson Drive, Bloomington, IN 47403

© Copyright 2025. All Rights Reserved by MedPath